Precision AQ will have 32 accepted posters, 2 podium presentations, 1 workshop, and 2 posters recognized among the top 5% of submissions at ISPOR Europe 2026.

Precision AQ is the commercialization partner of choice for biopharma innovators, market access leaders, and brand strategists. Trusted by all 30 of the world’s top pharmaceutical companies and leading biotechs, we specialize in turning complex data into clear, actionable strategies that accelerate access to innovation, including launching more than 450 drugs across all therapeutic areas. We believe access is enabled by evidence, empathy, and precision. We combine deep domain expertise with technology to turn fragmented data into clarity. Our global capabilities include: - Market access strategy and commercial consulting - Health economics and outcomes research (HEOR) - Medical communications - Market access marketing and omnichannel solutions - Advertising, branding, and public relations - Investor relations and external communications - Data and product solutions We help teams navigate payer, provider, and patient dynamics, delivering strategies that move markets- and lives- forward.